Medico Intercontinental Ltd

Medico Intercontinental Ltd has issued a notice for its 42nd Annual General Meeting (AGM) scheduled for September 30, 2026. The notice, compliant with SEBI regulations, includes the Annual Report for fiscal year 2025-26. Key dates include the book closure from September 24th to September 30th, 2026, and e-voting commencing on September 27th and concluding on September 29th, 2026. The AGM will address resolutions and review the company's performance, including its strategic investment in Calborn Lifescience Private Limited, which became a subsidiary during the year.

Medico Intercontinental Ltd. has released its Annual Report for the fiscal year 2025-26 and announced the schedule for its 42nd Annual General Meeting (AGM). The AGM is scheduled for September 30th, 2026, with e-voting commencing on September 27th and concluding on September 29th, 2026. The report details the company's performance, including a strategic investment in Calborn Lifescience Private Limited, which now operates as a subsidiary. Despite Calborn Lifescience incurring losses during its development and scaling phase, Medico Intercontinental expresses confidence in its future profitability and contribution to overall growth. The company also highlights its ongoing focus on expanding its product portfolio, strengthening customer relationships, and enhancing operational efficiencies.

Medico Intercontinental Ltd announced that its Board of Directors, in a meeting held on August 14, 2026, approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company also approved the notice for the Annual General Meeting (AGM), scheduled for September 30, 2026, to be held via Video Conferencing. The cut-off date for the AGM is September 23, 2026, with the register of members and share transfer books closed from September 24 to September 30, 2026. E-voting will be open from September 27 to September 29, 2026. M/s. V Goswami & Co, the statutory auditors, have issued a limited review report on the financial results. The Board meeting commenced at 1:00 PM and concluded at 4:20 PM.

Medico Intercontinental Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from July 1, 2026, until 48 hours after the declaration of the company's unaudited financial results for the quarter ended June 30, 2026. During this period, all designated individuals and their relatives are prohibited from trading in the company's securities.

Samir Shah, along with Persons Acting in Concert (PACs), has acquired 1,36,886 equity shares, representing 1.37% of the total share capital, in Medico Intercontinental Limited (MIL) through open market purchases between June 3, 2026, and June 24, 2026. This acquisition increases the total shareholding of Samir Shah and PACs to 60.48% (60,47,711 shares). The disclosure was made in accordance with SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Medico Intercontinental Ltd has announced that Mr. Samir Dilipkumar Shah, Promoter and Managing Director, acquired 1,36,886 equity shares of the company through open market purchases between June 3, 2026, and June 24, 2026. This disclosure is made in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The company has submitted the requisite disclosure to the stock exchange for record.

Medico Intercontinental Ltd has re-appointed M/s. MJV & Co, Chartered Accountants, Ahmedabad, as its Internal Auditor for the financial year 2026-27. The decision was approved by the Board of Directors in their meeting held on May 22, 2026. The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Medico Intercontinental Ltd. approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, along with the auditor's report by M/s. V Goswami & Co. The board also approved the re-appointment of M/s. MJV & Co as Internal Auditor for FY 2026-27 and various company policies. The board meeting was held on May 22, 2026, from 12:30 PM to 12:50 PM.

Medico Intercontinental Ltd's board approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board also approved the re-appointment of M/s. MJV & Co as the Internal Auditor for FY 2026-27 and various company policies. The meeting, based on the recommendation of the Audit Committee and Nomination and Remuneration Committee, took place on May 22, 2026.

Medico Intercontinental Ltd has announced the closure of the 'Trading Window' for dealing in the securities of the company. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and BSE Limited's circular no. LIST/COMP/01/2019-20 dated 2nd April, 2019. The closure will be effective from 1st April, 2026 and will remain in force for all designated persons and their immediate relatives until 48 hours after the declaration of the audited financial results for the quarter and financial year ending March 31, 2026. All designated persons and their immediate relatives have been advised not to trade in the securities of the company during this period.